CoChat

First evaluation of wearable radiation protection for human deep space exploration, as flown on Artemis I

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; 14 of the 57 sources its claims cite were checked for support.

Abstract

With preparations underway for extended-duration crewed deep space missions, the health risks of solar particle events (SPEs) to astronauts are becoming increasingly pertinent. To address this hazard, the AstroRad vest, a personal radiation shielding garment providing targeted organ protection, was tested during Artemis I. Two anthropomorphic female phantoms, equipped with internal and external passive and active dosimeters, were flown aboard the Orion spacecraft: one unshielded and the other wearing AstroRad. Inner Van Allen belt transit active dosimeter measurements were extrapolated to simulate SPE scenarios, predicting effective dose reductions of ∼60% for an August 1972-like SPE and nearly 40% for an October 1989-like SPE, varying slightly with anatomical model. Such reductions could spare astronauts the equivalent of up to 193 and 131 days of deep space radiation exposure, respectively. These findings demonstrate that wearable shielding such as AstroRad could serve as a vital element for safe and sustainable human deep space exploration.

Overview

CoChat Summary

## TL;DR

This paper uses Artemis I dosimeter data plus Monte Carlo simulations to estimate how much the AstroRad wearable radiation vest would reduce astronaut dose during major solar particle events (SPEs). It finds large modeled benefits: about 60% dose reduction for an August 1972–like SPE and about 39% for an October 1989–like SPE, with targeted shielding outperforming a uniform full-body suit.

## Key findings

  • In the Artemis I inner Van Allen belt transit, the vest was associated with a total effective dose reduction of 25.8 ± 0.4% for the phantom wearing AstroRad, from 1.61 ± 0.005 to 1.19 ± 0.006 mSv.
  • For an August 1972–like SPE, the vest was predicted to reduce total effective dose from 222.3 to 87.5 mSv (60.7%) for the torso phantom; with a whole-body female phantom, from 204.2 to 85.3 mSv (58.2%).
  • For an October 1989–like SPE, the vest was predicted to reduce total effective dose from 233.5 to 143.6 mSv (38.5%) for the torso phantom; with a whole-body female phantom, from 219.0 to 138.2 mSv (36.9%).
  • The targeted AstroRad design improved effective-dose reduction by ~30% compared with a uniform full-body HDPE suit of the same mass.
  • The paper estimates the vest could extend permissible spaceflight time by 59 to 193 days for an August 1972–like SPE and 40 to 131 days for an October 1989–like SPE, depending on solar-cycle phase.

## Methods

  • The study used the MARE experiment on Artemis I, with two anthropomorphic female phantoms in Orion: Zohar wearing AstroRad and Helga unshielded as baseline.
  • Dose was measured with active dosimeters (DLR M-42s and NASA CADs) placed internally and externally on the phantoms, then analyzed with GEANT4 Monte Carlo radiation transport simulations.
  • The Artemis I inner Van Allen belt data were first used to validate the simulation, then the model was extrapolated to historical SPE spectra using the August 1972 and October 1989 event parameterizations.

## Limitations

  • The paper states that the first validation phase relied on a shielding model that simplified the Orion hull to aluminum and polyethylene and did not account for many nonstructural interior objects, which may affect secondary radiation production.
  • It also notes that the AE9/AP9 trapped-radiation models are climatological and do not capture the exact Artemis I spectrum or radiation directionality; this is stated in the paper as a source of uncertainty.
  • Evident from the text: the SPE results are model-based extrapolations from Artemis I inner Van Allen belt data, so the core efficacy estimates are not direct measurements of an SPE.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1126/sciadv.adz1892

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. The Matroshka AstroRad Radiation Experiment. Illustration (A) and preflight photograph (B) of the MARE inside the Artemis I Orion spacecraft. Credit: NASA/Lockheed Martin/DLR.
Fig. 1. The Matroshka AstroRad Radiation Experiment. Illustration (A) and preflight photograph (B) of the MARE inside the Artemis I Orion spacecraft. Credit: NASA/Lockheed Martin/DLR.CC BY · PubMed Central
Fig. 2. AstroRad vest design and internal structure. (A) AstroRad vest diagram with labeled target organs, adapted under license from 3dMediSphere/Shutterstock.com. (B) Section of an AstroRad shielding panel with tessellated hexagonal shielding components of varying thickness (denoted by color), demonstrating the flexibility of this structure.
Fig. 2. AstroRad vest design and internal structure. (A) AstroRad vest diagram with labeled target organs, adapted under license from 3dMediSphere/Shutterstock.com. (B) Section of an AstroRad shielding panel with tessellated hexagonal shielding components of varying thickness (denoted by color), demonstrating the flexibility of this structure.CC BY · PubMed Central
Fig. 3. The MARE phantom. (A) Photo of the CIRS ATOM 702 Adult Female phantom, “Helga.” (B) Transverse slice from the Helga phantom exhibiting various tissues and organs (denoted by coloration) as well as the TLD grid. (C) Digital XCAT representation of the CIRS ATOM 702 Adult Female phantom.
Fig. 3. The MARE phantom. (A) Photo of the CIRS ATOM 702 Adult Female phantom, “Helga.” (B) Transverse slice from the Helga phantom exhibiting various tissues and organs (denoted by coloration) as well as the TLD grid. (C) Digital XCAT representation of the CIRS ATOM 702 Adult Female phantom.CC BY · PubMed Central
Fig. 4. MARE active detector placement. (A) Internal-body view of the phantom showing the M-42 Split (internal) active detector placement for both Helga and Zohar (left/right lung, stomach, uterus, and spine). (B) External active detector placement for Helga showing the CADs (red), M-42 Compact detectors (blue), and the M-42 Split battery packs (yellow). (C) Diagram of the M-42 Split detector system clarifying the location of the detector, which is placed inside the phantom, and the battery pack, which hangs outside the phantom. (D) Active detector placement for Zohar (shown with a semitransparent AstroRad vest). The total number of active radiation detectors used across both phantoms was 34 (16 × DLR M-42 and 18 × NASA CAD).
Fig. 4. MARE active detector placement. (A) Internal-body view of the phantom showing the M-42 Split (internal) active detector placement for both Helga and Zohar (left/right lung, stomach, uterus, and spine). (B) External active detector placement for Helga showing the CADs (red), M-42 Compact detectors (blue), and the M-42 Split battery packs (yellow). (C) Diagram of the M-42 Split detector system clarifying the location of the detector, which is placed inside the phantom, and the battery pack, which hangs outside the phantom. (D) Active detector placement for Zohar (shown with a semitransparent AstroRad vest). The total number of active radiation detectors used across both phantoms was 34 (16 × DLR M-42 and 18 × NASA CAD).CC BY · PubMed Central
Fig. 5. Validation/calibration phase simulation setup. GEANT4 visualization of the validation/calibration phase simulation setup for Zohar (left) and Helga (right) XCAT digital torso phantoms. Detectors are shown in yellow, PEEK support rod and Ultem dosimeter holder frames in purple, steel belt in gray, and AstroRad vest in black. The spacecraft hull is shown with darker shading denoting increased shielding thickness. Several simulated primary proton tracks are shown in blue, while secondary gammas and electrons are shown in green and red, respectively.
Fig. 5. Validation/calibration phase simulation setup. GEANT4 visualization of the validation/calibration phase simulation setup for Zohar (left) and Helga (right) XCAT digital torso phantoms. Detectors are shown in yellow, PEEK support rod and Ultem dosimeter holder frames in purple, steel belt in gray, and AstroRad vest in black. The spacecraft hull is shown with darker shading denoting increased shielding thickness. Several simulated primary proton tracks are shown in blue, while secondary gammas and electrons are shown in green and red, respectively.CC BY · PubMed Central
Fig. 6. Simulation validation results. Comparison of simulated (hashed bars) versus actual (solid bars) M-42 Helga (A) and Zohar (B) and CAD Helga (C) and Zohar (D) dosimeter data for the Artemis I inner Van Allen belt crossing. Coloring corresponds to detector colors in Fig. 4, i.e., blue for external M-42s, yellow for internal M-42s, and red for CADs. Error bars represent 95% confidence intervals.
Fig. 6. Simulation validation results. Comparison of simulated (hashed bars) versus actual (solid bars) M-42 Helga (A) and Zohar (B) and CAD Helga (C) and Zohar (D) dosimeter data for the Artemis I inner Van Allen belt crossing. Coloring corresponds to detector colors in Fig. 4, i.e., blue for external M-42s, yellow for internal M-42s, and red for CADs. Error bars represent 95% confidence intervals.CC BY · PubMed Central
Fig. 7. Simulated inner Van Allen belt dose maps for Helga and Zohar during Artemis I. Coronal and sagittal medial slices through the 3D NASA dose equivalent maps for Helga (left) and Zohar (right) obtained from the Artemis I inner Van Allen belt transit simulations. The dose hotspots in the lungs and anterior inferior body are due to the aluminum outer casings of the left and right lung and uterus M-42 detectors. These dose hotspots in aluminum do not significantly affect the dose readings by the silicon detectors within the aluminum casings. The vertical line with increased dose in the sagittal view is due to the PEEK support rod.
Fig. 7. Simulated inner Van Allen belt dose maps for Helga and Zohar during Artemis I. Coronal and sagittal medial slices through the 3D NASA dose equivalent maps for Helga (left) and Zohar (right) obtained from the Artemis I inner Van Allen belt transit simulations. The dose hotspots in the lungs and anterior inferior body are due to the aluminum outer casings of the left and right lung and uterus M-42 detectors. These dose hotspots in aluminum do not significantly affect the dose readings by the silicon detectors within the aluminum casings. The vertical line with increased dose in the sagittal view is due to the PEEK support rod.CC BY · PubMed Central
Fig. 8. SPE extrapolation simulation setup with the ATOM torso phantom. (A) SPE extrapolation simulation setup visualized in GEANT4 with spherical hull of uniform thickness for Zohar (left, with AstroRad shown in black) and Helga (right) XCAT digital phantoms. (B) Distribution of hull thicknesses (in grams per square centimeter) versus compute core ID. (C) Hull material composition versus compute core ID.
Fig. 8. SPE extrapolation simulation setup with the ATOM torso phantom. (A) SPE extrapolation simulation setup visualized in GEANT4 with spherical hull of uniform thickness for Zohar (left, with AstroRad shown in black) and Helga (right) XCAT digital phantoms. (B) Distribution of hull thicknesses (in grams per square centimeter) versus compute core ID. (C) Hull material composition versus compute core ID.CC BY · PubMed Central
Fig. 9. Dose maps with and without AstroRad resulting from the SPE extrapolation simulations using the ATOM torso phantom. Coronal and sagittal medial slices through the 3D NASA dose equivalent maps for Helga (left) and Zohar (right) as exposed to the August 1972 SPE (A) and the October 1989 SPE (B). Note the different color scale between the 1972 SPE and 1989 SPE dose maps.
Fig. 9. Dose maps with and without AstroRad resulting from the SPE extrapolation simulations using the ATOM torso phantom. Coronal and sagittal medial slices through the 3D NASA dose equivalent maps for Helga (left) and Zohar (right) as exposed to the August 1972 SPE (A) and the October 1989 SPE (B). Note the different color scale between the 1972 SPE and 1989 SPE dose maps.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 2 Not valid · 14 Not checked · 54 Own results and interpretations

51 more claims · 3 with their cited sources checked

Create a free account to see all 80 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 20

Create a free account to see these claims.

Citations

Cites

Show all 67 references

Metadata

Authors
Houri, J. M., Berger, T., Gaza, R., Hussein, H., Schwarz, S., Waterman, G., Matthiä, D., Marsalek, K., Przybyla, B., Aeckerlein, J., Radenhaeuser, M., Kasemann, M., Coderre, K., Segars, W. P., Samei, E., Kapadia, A. J., Lee, K., Laramore, D., George, S. P., Semones, E., & Milstein, O.
Affiliations
  • StemRad Inc., Tampa, FL, USA.
  • Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR) (DE)
  • Leidos (United States) (US)
  • Lockheed Martin (United States) (US)
  • Israel Space Agency (IL)
  • German Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Cologne, Germany.
  • Duke University (US)
  • Oak Ridge National Laboratory (US)
  • The Aerospace Corporation (US)
  • National Aeronautics and Space Administration (US)
Corresponding author
  • Houri, Jordan M.
  • Milstein, Oren
Venue
Science Advances
Published
2026-08-14
Volume
12
Issue
33
Pages
eadz1892-eadz1892
ISSN
2375-2548 (ISSN-L)
OpenAlex
W7202264997
Cited by
2
References
60
Citations by year
2026: 2
FWCI
7.30
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • elib (German Aerospace Center) (submittedVersion)
Funders
  • National Institutes of Health (R01EB001838, P41EB028744)
  • National Aeronautics and Space Administration (NNJ15HK11B)
  • Deutsches Zentrum für Luft- und Raumfahrt (2475019, 2475075)
  • Israel Space Agency (4501432315)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Health Sciences › Medicine › Physiology (medical) › Spaceflight effects on biology
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
Keywords
solar energetic particle events, astronaut radiation exposure, deep space exploration, Artemis I, Orion spacecraft, anthropomorphic phantom, passive dosimeters, radiation belts, effective dose reduction, crewed lunar missions
MeSH terms
Wearable Electronic Devices, Cosmic Radiation, Female, Humans, Radiation Protection, Space Flight, Astronauts, Phantoms, Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.